Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide in Relapsed or Refractory Primary-cutaneous Large B-cell Lymphoma (Leg-type)
NCT01556035Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Jul 2012
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in Primary cutaneous large B-cell lymphoma (PCDLBCL), sponsored by Centre Hospitalier Universitaire de Bordeaux. Started Jul 2012; status: completed.
02
Drugs
lenalidomide
03
Conditions
Primary cutaneous large B-cell lymphoma (PCDLBCL)
Beyond the preview
Go deeper on NCT01556035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01556035.